Werewolf Therapeutics Inc (HOWL)
6.07
-0.01
(-0.16%)
USD |
NASDAQ |
May 03, 16:00
6.01
-0.06
(-0.99%)
After-Hours: 20:00
Werewolf Therapeutics Price: 6.07 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 6.13 | 6.342 | 5.78 | 6.07 | 138941.0 |
May 02, 2024 | 6.12 | 6.335 | 5.93 | 6.08 | 90502.00 |
May 01, 2024 | 6.24 | 6.486 | 5.96 | 6.02 | 197079.0 |
Apr 30, 2024 | 6.61 | 6.74 | 6.19 | 6.24 | 143426.0 |
Apr 29, 2024 | 6.73 | 6.89 | 6.28 | 6.66 | 125968.0 |
Apr 26, 2024 | 6.22 | 6.78 | 6.10 | 6.75 | 82150.00 |
Apr 25, 2024 | 6.28 | 6.30 | 6.00 | 6.21 | 78714.00 |
Apr 24, 2024 | 6.38 | 6.65 | 6.24 | 6.39 | 81698.00 |
Apr 23, 2024 | 6.13 | 6.44 | 5.96 | 6.44 | 393989.0 |
Apr 22, 2024 | 5.97 | 6.158 | 5.771 | 6.09 | 241411.0 |
Apr 19, 2024 | 5.79 | 5.975 | 5.62 | 5.90 | 120925.0 |
Apr 18, 2024 | 5.96 | 6.12 | 5.75 | 5.87 | 118988.0 |
Apr 17, 2024 | 5.57 | 6.04 | 5.55 | 5.84 | 409947.0 |
Apr 16, 2024 | 5.53 | 5.82 | 5.34 | 5.61 | 425685.0 |
Apr 15, 2024 | 4.77 | 5.49 | 4.77 | 5.49 | 261486.0 |
Apr 12, 2024 | 5.08 | 5.08 | 4.50 | 4.69 | 413090.0 |
Apr 11, 2024 | 5.36 | 5.38 | 4.865 | 5.07 | 245868.0 |
Apr 10, 2024 | 5.21 | 5.32 | 5.08 | 5.29 | 87043.00 |
Apr 09, 2024 | 5.38 | 5.40 | 5.27 | 5.35 | 70160.00 |
Apr 08, 2024 | 5.90 | 5.99 | 5.25 | 5.38 | 280604.0 |
Apr 05, 2024 | 6.00 | 6.10 | 5.80 | 5.92 | 92776.00 |
Apr 04, 2024 | 6.03 | 6.325 | 5.97 | 6.00 | 160261.0 |
Apr 03, 2024 | 6.33 | 6.385 | 6.02 | 6.02 | 126125.0 |
Apr 02, 2024 | 6.34 | 6.38 | 5.92 | 6.06 | 80555.00 |
Apr 01, 2024 | 6.54 | 6.74 | 6.16 | 6.38 | 86098.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.53
Minimum
Dec 07 2022
20.31
Maximum
Jul 02 2021
6.694
Average
4.64
Median
Jun 15 2022
Price Benchmarks
CEL-SCI Corp | 1.63 |
AIM ImmunoTech Inc | 0.4048 |
IGC Pharma Inc | 0.5112 |
NovaBay Pharmaceuticals Inc | 0.0949 |
Protalix BioTherapeutics Inc | 1.14 |
Price Related Metrics
PS Ratio | 10.85 |
Price to Book Value | 2.329 |
Earnings Yield | -17.13% |
Market Cap | 259.41M |